Jubilant Pharmova reports net profit of Rs 214 crore in Q4; FY21 profit at Rs 836 crore

Jubilant Pharmova reports net profit of Rs 214 crore in Q4; FY21 profit at Rs 836 crore The drug firm said it plans to incur a capital expenditure of Rs 700-800 crore in the current fiscal on the addition of a new high speed fill and finish line with lyophilizer at Spokane site (US) and expansion of CRDS (Contract Research and Development Services) capacity.

from Moneycontrol Results News https://ift.tt/3vWFWCn
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...